Clinical and research tests for C0026847 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 2 of 2

Next >Last >>

Results: 21 to 39 of 39

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Horizon 137 Natera, Inc. United States	135	137	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 274 Natera, Inc. United States	265	274	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon Cystic Fibrosis, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc. United States	3	3	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc. United States	2	2	E Enzyme assay E Sequence analysis of select exons
Horizon 14 plus TSE Natera, Inc. United States	15	16	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 14 Natera, Inc. United States	15	15	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon Duchenne Muscular Dystrophy, Cystic Fibrosis and Spinal Muscular Atrophy Natera, Inc. United States	4	3	E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon Cystic Fibrosis and Spinal Muscular Atrophy Natera, Inc. United States	2	2	E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon Duchenne Muscular Dystrophy, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc. United States	4	3	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon Duchenne Muscular Dystrophy, Cystic Fibrosis, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc. United States	5	4	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon DMD and Spinal Muscular Atrophy Natera, Inc. United States	3	2	E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon 4 Plus TSE Natera, Inc. United States	6	5	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon Spinal Muscular Atrophy Natera, Inc. United States	1	1	E Sequence analysis of select exons
Horizon 3 Plus TSE Natera, Inc. United States	4	4	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 4 Natera, Inc. United States	5	4	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 3 Natera, Inc. United States	3	3	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Spinal Muscular Atrophy via SMN1/SM2 analysis Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates	1	1	E Sequence analysis of select exons
Genetic Carrier Screen, (CF, FXS, and SMA) with Reflex to Methylation ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States	3	4	D Deletion/duplication analysis E Sequence analysis of select exons
Spinal Muscular Atrophy Defense Health Agency Genetics Reference Laboratory United States Air Force United States	1	1	E Sequence analysis of select exons

<< First < Prev

Page 2 of 2

Next >Last >>

Results: 21 to 39 of 39

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.